Afinitor
Payments companies reported to CMS as associated with Afinitor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Afinitor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Afinitor
These are the largest totals companies reported as associated with Afinitor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dennis Slamon | Los Angeles, CA | Hematology & Oncology | $75.97 |
| Meghan Brennan | Elmhurst, IL | Anesthesiology | $75.97 |
| Artin Minaeian | Glendale, CA | Neurology (Psychiatry & Neurology) | $28.46 |
| Vahe Akopian | Glendale, CA | Neurology (Psychiatry & Neurology) | $28.46 |
| Alexander Gevorgyan | Glendale, CA | Clinical Neurophysiology | $28.46 |
| Donna Doerffler | Indianapolis, IN | Nurse Practitioner | $13.44 |
| Sumona Kabir | Fort Wayne, IN | Internal Medicine | $13.44 |
| Matthew Brier | Saint Louis, MO | Neurology (Psychiatry & Neurology) | $9.79 |
| Michael Di Giovanna | North Massapequa, NY | Internal Medicine | $2.57 |
Prescribed Afinitor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.